ESPEN Guidelines on Enteral Nutrition: Gastroenterology

Clinical Nutrition

Volumn 25, Issue 2, 2006, Pages 260-274

  Lochs, H ^a   Dejong, C ^b   Hammarqvist, F ^c   Hebuterne, X ^d   Leon Sanz, M ^e   Schutz T ^a   van Gemert, W ^b   van Gossum, A ^f   Valentini, L ^a   Lubke H ^g   Bischoff, S ^g   Engelmann, N ^g   Thul, P ^g  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f ERASME HOSPITAL   (Belgium)

^g NONE

Author keywords

Clinical practice; Crohn s disease; Enteral nutrition; Evidence based; Guideline; Malnutrition; Oral nutritional supplements; Short bowel syndrome; Tube feeding; Ulcerative colitis; Undernutrition

Indexed keywords

AZATHIOPRINE; BUTYRIC ACID; CORTICOSTEROID; GLUTAMINE; IMMUNOSUPPRESSIVE AGENT; IRON; MERCAPTOPURINE; MESALAZINE; OMEGA 3 FATTY ACID; RECOMBINANT GROWTH HORMONE; SALAZOSULFAPYRIDINE;

ADJUVANT THERAPY; ARTICLE; CLINICAL TRIAL; CROHN DISEASE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ENTERIC FEEDING; EVIDENCE BASED MEDICINE; HUMAN; MALABSORPTION; MALNUTRITION; META ANALYSIS; NUTRITIONAL COUNSELING; NUTRITIONAL INTOLERANCE; NUTRITIONAL STATUS; PRACTICE GUIDELINE; QUALITY OF LIFE; SHORT BOWEL SYNDROME; SYSTEMATIC REVIEW; TOTAL PARENTERAL NUTRITION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TUBE FEEDING; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CROHN DISEASE; ENTERAL NUTRITION; EUROPE; GASTROENTEROLOGY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; SHORT BOWEL SYNDROME;

EID: 33744535699     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2006.01.007     Document Type: Article

References (148)

1. Zurita V.F., Rawls D.E., and Dyck W.P. Nutritional support in inflammatory bowel disease. Dig Dis 503 (1995) 92-107
2. Fleming C.R. Nutrition considerations in patients with Crohn's disease. Semin Colon Rectal Surg 5 (1994) 167-173
3. Weinsier R.L., and Heimburger D.C. Distinguishing malnutrition from disease: the search goes on. Am J Clin Nutr 66 (1997) 1063-1064
4. Jeejeebhoy K.N., Detsky A.S., and Baker J.P. Assessment of nutritional status. J Parenter Enteral Nutr 14 Suppl (1990) 193-196
5. Charney P. Nutrition assessment in the 1990s: where are we now?. Nutr Clin Prat 10 (1995) 131-139
6. Silk D.B.A., and Payne-James J. Inflammatory bowel disease: nutritional implications and treatment. Proc Nutr Soc 48 (1989) 355-361
7. Geerling B.J., Stockbruegger R.W., and Brummer R.J.M. Nutrition in inflammatory bowel disease. An update, Scand J Gastroenterol 230 Suppl (1999) 95-105
8. Gassull M.A., and Cabré E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 4 (2001) 561-569
9. Royall D., Greenberg G.R., Allard J.P., Baker J.P., and Jeejeebhoy K.N. Total enteral nutrition support improves body composition of patients with active Crohn's disease. J Parenter Enteral Nutr 19 (1995) 95-99
10. Valentin N., Neilsen O.V., and Olesen K.H. Muscle cell electrolytes in ulcerative colitis and Crohn's disease. Digestion 13 (1975) 284-290
11. Sjogren A., Floren C.H., and Nilsson A. Evaluation of magnesium status in Crohn's disease as assessed by intracellular analysis and intravenous magnesium infusion. Scand J Gastroenterol 23 (1988) 555-561
12. Geerling B.J., Badart-Smook A., Stockbrugger R.W., and Brummer R.J. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 67 (1998) 919-926
13. Rath H.C., Caesar I., Roth M., and Scholmerich J. Nutritional deficiencies and complications in chronic inflammatory bowel diseases. Med Klin 93 (1998) 6-10
14. Maier-Dobersberger T., and Lochs H. Enteral supplementation of phosphate does not prevent hypophosphatemia during refeeding of cachectic patients. J Parenter Enteral Nutr 18 (1994) 182-184
15. Vogelsang H., Schofl R., Tillinger W., Ferenci P., and Gangl A. 25-hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency. Wien Klin Wochenschr 109 (1997) 678-682
16. Schoon E.J., Muller M.C., Vermeer C., Schurgers L.J., Brummer R.J., and Stockbrugger R.W. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?. Gut 48 (2001) 473-477
17. Behrend C., Jeppesen P.B., and Mortensen P.B. Vitamin B12 absorption after ileorectal anastomosis for Crohn's disease: effect of ileal resection and time span after surgery. Eur J Gastroenterol Hepatol 7 (1995) 397-400
18. Fernandez-Banares F., Abad-Lacruz A., Xiol X., et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 84 (1989) 744-748
19. Al Jaouni R., Hebuterne X., Pouget I., and Rampal P. Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition 16 (2000) 173-178
20. Stokes M.A., and Hill G.L. Total energy expenditure in patients with Crohn's disease: measurement by the combined body scan technique. J Parenter Enteral Nutr 17 (1993) 3-7
21. Capristo E., Addolorato G., Mingrone G., Greco A.V., and Gasbarrini G. Effect of disease localization on the anthropometric and metabolic features of Crohn's disease. Am J Gastroenterol 93 (1998) 2411-2419
22. Schneeweiss B., Lochs H., Zauner C., et al. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr 129 (1999) 844-848
23. Motil K.J., Grand R.J., Maletskos C.J., and Young V.R. The effect of disease, drug, and diet on whole body protein metabolism in adolescents with Crohn disease and growth failure. J Pediatr 101 (1982) 345-351
24. Rosenberg I.H., Bengoa J.M., and Sitrin M.D. Nutritional aspects of inflammatory bowel disease. Annu Rev Nutr 5 (1985) 463-484
25. Heatley R.V. Assessing nutritional state in inflammatory bowel disease. Gut 27 Suppl 1 (1986) 61-66
26. Beeken W.L., Busch H.J., and Sylwester D.L. Intestinal protein loss in Crohn's disease. Gastroenterology 62 (1972) 207-215
27. Kanof M.E., Lake A.M., and Bayless T.M. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 95 (1988) 1523-1527
28. Seidman E.G. Nutritional management of inflammatory bowel disease. Gastroenterol Clin North Am 18 (1989) 129-155
29. Seidman E., LeLeiko N., Ament M., et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 12 (1991) 424-438
30. Belli D.C., Seidman E., Bouthillier L., et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 94 (1988) 603-610
31. Markowitz J., Grancher K., Rosa J., Aiges H., and Daum F. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 16 (1993) 373-380
32. Kirschner B.S. Growth and development in chronic inflammatory bowel disease. Acta Paediatr Scand 366 Suppl (1990) 98-104
33. Hildebrand H., Karlberg J., and Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 18 (1994) 165-173
34. Geerling B.J., Badart-Smook A., Stockbrugger R.W., and Brummer R.J. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 54 (2000) 514-521
35. Jahnsen J., Falch J.A., Mowinckel P., and Aadland E. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol 98 (2003) 1556-1562
36. Capristo E., Mingrone G., Addolorato G., Greco A.V., and Gasbarrini G. Metabolic features of inflammatory bowel disease in a remission phase of the disease activity. J Intern Med 243 (1998) 339-347
37. Lanfranchi G.A., Brignola C., Campieri M., et al. Assessment of nutritional status in Crohn's disease in remission or low activity. Hepatogastroenterology 31 (1984) 129-132
38. Capristo E., De Gaetano A., Mingrone G., et al. Multivariate identification of metabolic features in inflammatory bowel disease. Metabolism 48 (1999) 952-956
39. Muller M.J., Schmidt L.U., Korber J., von zur M.A., Canzler H., and Schmidt F.W. Reduced metabolic efficiency in patients with Crohn's disease. Dig Dis Sci 38 (1993) 2001-2009
40. Semeao E.J., Jawad A.F., Stouffer N.O., Zemel B.S., Piccoli D.A., and Stallings V.A. Risk factors for low bone mineral density in children and young adults with Crohn's disease. J Pediatr 135 (1999) 593-600
41. Issenman R.M. Bone mineral metabolism in pediatric inflammatory bowel disease. Inflamm Bowel Dis 5 (1999) 192-199
42. Harries A.D., Brown R., Heatley R.V., Williams L.A., Woodhead S., and Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 26 (1985) 1197-1203
43. Haugeberg G., Vetvik K., Stallemo A., Bitter H., Mikkelsen B., and Stokkeland M. Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study. Scand J Gastroenterol 36 (2001) 759-765
44. Bernstein C.N., Seeger L.L., Sayre J.W., Anton P.A., Artinian L., and Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 10 (1995) 250-256
45. Stockbrugger R.W., Schoon E.J., Bollani S., et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther 16 (2002) 1519-1527
46. Klaus J., Armbrecht G., Steinkamp M., et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 51 (2002) 654-658
47. Habtezion A., Silverberg M.S., Parkes R., Mikolainis S., and Steinhart A.H. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 8 (2002) 87-92
48. Bernstein C.N., Blanchard J.F., Leslie W., Wajda A., and Yu B.N. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 133 (2000) 795-799
49. Vogelsang H., Klamert M., Resch H., and Ferenci P. Dietary vitamin D intake in patients with Crohn's disease. Wien Klin Wochenschr 107 (1995) 578-581
50. Cucino C., and Sonnenberg A. Cause of death in patients with inflammatory bowel disease. Inflamm Bowel Dis 7 (2001) 250-255
51. Lindor K.D., Fleming C.R., and Ilstrup D.M. Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn's disease. Mayo Clin Proc 60 (1985) 393-396
52. Higgens C.S., Keighley M.R., and Allan R.N. Impact of preoperative weight loss and body composition changes on postoperative outcome in surgery for inflammatory bowel disease. Gut 25 (1984) 732-736
53. Aiges H., Markowitz J., Rosa J., and Daum F. Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease. Gastroenterology 97 (1989) 905-910
54. Harries A.D., Jones L.A., Danis V., et al. Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet 1 (1983) 887-890
55. Azcue M., Rashid M., Griffiths A., and Pencharz P.B. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut 41 (1997) 203-208
56. Motil K.J., Grand R.J., Davis-Kraft L., Ferlic L.L., and Smith E.O. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 105 (1993) 681-691
57. Messori A., Trallori G., D'Albasio G., Milla M., Vannozzi G., and Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol 31 (1996) 267-272
58. Griffiths A.M., Ohlsson A., Sherman P.M., and Sutherland L.R. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 108 (1995) 1056-1067
59. Bremner A.R., and Beattie R.M. Therapy of Crohn's disease in childhood. Expert Opin Pharmacother 3 (2002) 809-825
60. Zachos M., Tondeur M., and Griffiths A.M. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev CD000542 (2001)
61. O'Morain C., Segal A.W., and Levi A.J. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed) 288 (1984) 1859-1862
62. Gorard D.A., Hunt J.B., Payne-James J.J., et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 34 (1993) 1198-1202
63. Lindor K.D., Fleming C.R., Burnes J.U., Nelson J.K., and Ilstrup D.M. A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn's disease. Mayo Clin Proc 67 (1992) 328-333
64. Gonzalez-Huix F., de Leon R., Fernandez-Banares F., et al. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut 34 (1993) 778-782
65. Malchow H., Steinhardt H.J., Lorenz-Meyer H., et al. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Scand J Gastroenterol 25 (1990) 235-244
66. Lochs H., Steinhardt H.J., Klaus-Wentz B., et al. Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV. Gastroenterology 101 (1991) 881-888
67. Seidman E.G. Semielemental diet versus prednisone in treatment of active Crohns's disease in children and adolescents. Gastroenterology 104 (1993) A778
68. Greenberg G.R., Fleming C.R., Jeejeebhoy K.N., Rosenberg I.H., Sales D., and Tremaine W.J. Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut 29.1309-15 (1988)
69. Lochs H., Egger-Schodl M., Potzi R., Kappel C., and Schuh R. Enteral feeding-an alternative to parenteral feeding in the treatment of Crohn disease?. Leber Magen Darm 14 (1984) 64-67
70. Lochs H., Meryn S., Marosi L., Ferenci P., and Hörtnagl H. Has total bowel rest a beneficial effect in the treatment of Crohn's disease. Clin Nutr 2 (1983) 61-64
71. Wright R.A., and Adler E.C. Peripheral parenteral nutrition is no better than enteral nutrition in acute exacerbation of Crohn's disease: a prospective trial. J Clin Gastroenterol 12 (1990) 396-399
72. Royall D., Jeejeebhoy K.N., Baker J.P., et al. Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut 35 (1994) 783-787
73. Verma S., Kirkwood B., Brown S., and Giaffer M.H. Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Dig Liver Dis 32 (2000) 769-774
74. Wilschanski M., Sherman P., Pencharz P., Davis L., Corey M., and Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 38 (1996) 543-548
75. Hirakawa H., Fukuda Y., Tanida N., Hosomi M., and Shimoyama T. Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn's disease. Gastroenterol Jpn 28 (1993) 379-384
76. Blondel-Kucharski F., Chircop C., Marquis P., et al. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol 96 (2001) 2915-2920
77. Malone M. Quality of life of patients receiving home parenteral or enteral nutrition support. Pharmacoeconomics 5 (1994) 101-108
78. Jones B.J.M., Payne S., and Silk D.B.A. Indications for pump-assisted enteral feeding. Lancet (1980) 1057-1058
79. Mahajan L., Oliva L., Wyllie R., Fazio V., Steffen R., and Kay M. The safety of gastrostomy in patients with Crohn's disease. Am J Gastroenterol 92 (1997) 985-988
80. Anstee Q.M., and Forbes A. The safe use of percutaneous gastrostomy for enteral nutrition in patients with Crohn's disease. Eur.J Gastroenterol Hepatol 12 (2000) 1089-1093
81. Rees R.G., Keohane P.P., Grimble G.K., Frost P.G., Attrill H., and Silk D.B. Elemental diet administered nasogastrically without starter regimens to patients with inflammatory bowel disease. J Parenter Enteral Nutr 10 (1986) 258-262
82. Schwab D., Raithel M., and Hahn E.G. Enteral nutrition in acute Crohn disease. Z.Gastroenterol 36 (1998) 983-995
83. Verma S., Brown S., Kirkwood B., and Giaffer M.H. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol 95 (2000) 735-739
84. Mansfield J.C., Giaffer M.H., and Holdsworth C.D. Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease. Gut 36 (1995) 60-66
85. Park H.R., Galloway A., Danesh J.Z.D., and Russell R. Double-blind controlled trial of elemental and polymeric diets as primary therapy in active Crohn's disease. Eur J Gastroenterol Hepatol 3 (1991) 483-490
86. Middleton S.J., Riordan A.M., and Hunter A. Comparison of elemental and peptide-based diets in the treatment of acute Crohn's disease. Ital J Gastroenterol 23 (1991) 609A
87. Raouf A.H., Hildrey V., Daniel J., et al. Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge. Gut 32 (1991) 702-707
88. Rigaud D., Cosnes J., Le Quintrec Y., Rene E., Gendre J.P., and Mignon M. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut 32 (1991) 1492-1497
89. Sakurai T., Matsui T., Yao T., et al. Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas. J Parenter Enteral Nutr 26 (2002) 98-103
90. Khoshoo V., Reifen R., Neuman M.G., Griffiths A., and Pencharz P.B. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn's disease. J Parenter Enteral Nutr 20 (1996) 401-405
91. Gassull M.A., Fernandez-Banares F., Cabre E., et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 51 (2002) 164-168
92. Akobeng A.K., Miller V., Stanton J., Elbadri A.M., and Thomas A.G. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 30 (2000) 78-84
93. Den Hond E., Hiele M., Peeters M., Ghoos Y., and Rutgeerts P. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease. J Parenter Enteral Nutr 23 (1999) 7-11
94. Beattie R.M., Schiffrin E.J., Donnet-Hughes A., et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 8 (1994) 609-615
95. Fell J.M., Paintin M., Arnaud-Battandier F., et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 14 (2000) 281-289
96. Klein S., Meyer S., and OSullivan P. The metabolic impact of active ulcerative colitis* Energy expenditure and nitrogen balance. J Clin Gastroenterol 10 (1998) 34-40
97. Schreiber S., Howaldt S., Schnoor M., et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 334 (1996) 619-623
98. Gasche C., Dejaco C., Waldhoer T., et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 126 (1997) 782-787
99. Shike M., Harrison J.E., Sturtridge W.C., et al. Metabolic bone disease in patients receiving long-term total parenteral nutrition. Ann Intern Med 92 (1980) 343-350
100. Franklin J.L., and Rosenberg H.H. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine). Gastroenterology 64 (1973) 517-525
101. Lashner B.A. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 119 (1993) 549-554
102. Boot A.M., Bouquet J., Krenning E.P., and de Muinck Keizer-Schrama S.M. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 42 (1998) 188-194
103. Jahnsen J., Falch J.A., Aadland E., and Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 40 (1997) 313-319
104. Brandes J.W., Stenner A., and Martini G.A. Dietary habits of patients with ulcerative colitis. Z Gastroenterol 17 (1997) 834-842
105. Tragnone A., Valpiani D., Miglio F., et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 7 (1995) 47-51
106. Mingrone G., Benedetti G., Capristo E., et al. Twenty-four-hour energy balance in Crohn disease patients: metabolic implications of steroid treatment. Am J Clin Nutr 67 (1998) 118-123
107. Gasche C., Lomer M.C., Cavill I., and Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 53 (2004) 1190-1197
108. Rocchio M.A., Cha C.J., Haas K.F., and Randall H.T. Use of chemically defined diets in the management of patients with acute inflammatory bowel disease. Am J Surg 127 (1974) 469-475
109. Axelsson C., and Jarnum S. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand J Gastroenterol 12 (1977) 89-95
110. McIntyre P.B., Powell-Tuck J., Wood S.R., et al. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 27 (1986) 481-485
111. Gonzalez-Huix F., Fernandez-Banares F., Esteve-Comas M., et al. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol 88 (1993) 227-232
112. Stenson W.F., Cort D., Rodgers J., et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 116 (1992) 609-614
113. Hawthorne A.B., Daneshmend T.K., Hawkey C.J., et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 33 (1992) 922-928
114. Breuer R.I., Soergel K.H., Lashner B.A., et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut 40 (1997) 485-491
115. Vernia P., Marcheggiano A., Caprilli R., et al. Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 9 (1995) 309-313
116. Loeschke K., Ueberschaer B., Pietsch A., et al. n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 41 (1996) 2087-2094
117. Vanderhoof J.A., and Young R.J. Enteral and parenteral nutrition in the care of patients with short-bowel syndrome. Best Pract Res Clin Gastroenterol (2003) 997-1015
118. Ukleja A., Scolapio J.S., and Buchman A.L. Nutritional management of short bowel syndrome. Semin Gastrointest Dis (2002) 161-1688
119. Marotta R., and Floch M.H. Dietary therapy of steatorhoea. Gatroenterol Clin North Am 18 (1993) 485-508
120. Nightingale J.M., and Lennard-Jones J.E. The short bowel syndrome: what's new and old?. Dig Dis 11 (1993) 12-31
121. Woolf G.M., Miller C., Kurian R., and Jeejeebhoy K.N. Nutritional absorption in short bowel syndrome. Evaluation of fluid, calorie, and divalent cation requirements. Dig Dis Sci 32 (1987) 8-15
122. Messing B., Pigot F., Rongier M., Morin M.C., Ndeindoum U., and Rambaud J.C. Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology 100 (1991) 1502-1508
123. Jeppesen P.B., and Mortensen P.B. Intestinal failure defined by measurements of intestinal energy and wet weight absorption. Gut 46 (2000) 701-706
124. Nordgaard I., Hansen B.S., and Mortensen P.B. Colon as a digestive organ in patients with short bowel. Lancet 343 (1994) 373-376
125. Cosnes J., Gendre J.P., Evard D., and Le Quintrec Y. Compensatory enteral hyperalimentation for management of patients with severe short bowel syndrome. Am J Clin Nutr 41 (1985) 1002-1009
126. Ovensen L., Chu R., and Howard L. The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome. Am J Clin Nutr 38 (1983) 270-278
127. Purdum P.P., and Kirby D.F. Short-bowel syndrome: a review of the role of nutrition support. J Parenter Enteral Nutr 15 (1991) 93-101
128. Booth I.W. Enteral nutrition as primary therapy in short bowel syndrome. Gut 35 (1994) S69-S72
129. Carbonnel F., Cosnes J., Chevret S., et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. J Parenter Enteral Nutr 20 (1996) 275-280
130. Keller J., Panter H., and Layer P. Management of the short bowel syndrome after extensive small bowel resection. Best Pract Res Clin Gastroenterol 18 (2004) 977-992
131. Rodriguez D.J., and Clevenger F.W. Successful enteral refeeding after massive small bowel resection. West J Med 159 (1993) 192-194
132. Dudrick S.J., Latifi R., and Fosnocht D.E. Management of the short-bowel syndrome. Surg Clin North Am 71 (1991) 625-643
133. Griffin G.E., Fagan E.F., Hodgson H.J., and Chadwick V.S. Enteral therapy in the management of massive gut resection complicated by chronic fluid and electrolyte depletion. Dig Dis Sci 27 (1982) 902-908
134. Lennard-Jones J.E. Review article: practical management of the short bowel. Aliment Pharmacol Ther 8 (1994) 563-577
135. McIntyre P.B., Fitchew M., and Lennard-Jones J.E. Patients with a high jejunostomy do not need a special diet. Gastroenterology 91 (1986) 25-33
136. Suchner U., Senftleben U., Eckart T., et al. Enteral versus parenteral nutrition: effects on gastrointestinal function and metabolism. Nutrition 12 (1996) 13-22
137. Wicks C., Somasundaram S., Bjarnason I., et al. Comparison of enteral feeding and total parenteral nutrition after liver transplantation. Lancet 344 (1994) 837-840
138. Hadfield R.J., Sinclair D.G., Houldsworth P.E., and Evans T.W. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med 152 (1995) 1545-1548
139. Reynolds J.V., Kanwar S., Welsh F.K., et al. Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery?. J Parenter Enteral Nutr 21 (1997) 196-201
140. Hoensch H.P., Steinhardt H.J., Weiss G., Haug D., Maier A., and Malchow H. Effects of semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small intestinal mucosa in humans. Gastroenterology 86 (1984) 1519-1530
141. Lipman T.O. Grains or veins: is enteral nutrition really better than parenteral nutrition? A look at the evidence. J Parenter Enteral Nutr 22 (1998) 167-182
142. Cosnes J., and Carbonnel F. Oral and enteral nutrition management and drug treatment of short bowel syndrome. Clin Nutr 14 (1995) 16-20
143. Wilmore D.W., and Robinson M.K. Short bowel syndrome. World J Surg 24 (2000) 1486-1492
144. Byrne T.A., Persinger R.L., Young L.S., Ziegler T.R., and Wilmore D.W. A new treatment for patients with short-bowel syndrome: Growth hormone, glutamine, and a modified diet. Ann Surg 222 (1995) 243-254
145. Scolapio J.S., McGreevy K., Tennyson G.S., and Burnett O.L. Effect of glutamine in short-bowel syndrome. Clin Nutr 20 (2001) 319-323
146. Li L., and Irving M. The effectiveness of growth hormone, glutamine and a low-fat diet containing high-carbohydrate on the enhancement of the function of remnant intestine among patients with short bowel syndrome: a review of published trials. Clin Nutr 20 (2001) 199-204
147. Schütz T., Herbst B., and Koller M. Methodology for the development of the ESPEN Guidelines on Enteral Nutrition. Clin Nutr 25 2 (2006) 203-209
148. Lochs H., Allison S.P., Meier R., Pirlich M., Kondrup J., Schneider St., van den Berghe G., and Pichard C. Introductory to the ESPEN Guidelines on Enteral Nutrition: Terminology, Definitions and General Topics. Clin Nutr 25 2 (2006) 180-186